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Abstract
Background: Human influenza viruses are known to bind to sialic acid linked α2-6 to galactose,
but the binding specificity beyond that linkage has not been systematically examined. H3N2 human
influenza isolates lost binding to chicken red cells in the 1990s but viruses isolated since 2003 have
re-acquired the ability to agglutinate chicken erythrocytes. We have investigated specificity of
binding, changes in hemagglutinin sequence of the recent viruses and the role of sialic acid in
productive infection.
Results: Viruses that agglutinate, or do not agglutinate, chicken red cells show identical binding to
a Glycan Array of 264 oligosaccharides, binding exclusively to a subset of α2-6-sialylsaccharides.
We identified an amino acid change in hemagglutinin that seemed to correlate with chicken red cell
binding but when tested by mutagenesis there was no effect. Recombinant hemagglutinins
expressed on Sf-9 cells bound chicken red cells but the released recombinant baculoviruses
agglutinated only human red cells. Similarly, an isolate that does not agglutinate chicken red cells
show hemadsorption of chicken red cells to infected MDCK cells. We suggest that binding of
chicken red cells to cell surface hemagglutinin but not to virions is due to a more favorable
hemagglutinin density on the cell surface. We investigated whether a virus specific for α2-6
sialyloligosaccharides shows differential entry into cells that have varying proportions of α2-6 and
α2-3 sialic acids, including human A549 and HeLa cells with high levels of α2-6 sialic acid, and CHO
cells that have only α2-3 sialic acid. We found that the virus enters all cell types tested and
synthesizes viral nucleoprotein, localized in the nucleus, and hemagglutinin, transported to the cell
surface, but infectious progeny viruses were released only from MDCK cells.
Conclusion: Agglutination of chicken red cells does not correlate with altered binding to any
oligosaccharide on the Glycan Array, and may result from increased avidity due to density of
hemagglutinin and not increased affinity. Absence of α2-6 sialic acid does not protect a cell from
influenza infection and the presence of high levels of α2-6-sialic acids on a cell surface does not
guarantee productive replication of a virus with α2-6 receptor specificity.
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Background
Influenza hemagglutinin binds to sialic acids attached to
membrane glycosphingolipids, proteoglycans, and glyco-
proteins [1]. It was shown that the linkage between sialic
acid and the second sugar (usually galactose) could deter-
mine whether an influenza virus binds to avian or human
cells [2,3], and that a single mutation in the hemaggluti-
nin (HA) was sufficient to change binding from α2-3 to
α2-6 and host cells from avian to human, or vice versa
[4,5]. Now it is generally accepted that human influenza
viruses bind to α2-6 sialic acids and avian viruses bind to
α2-3 sialic acids [6-8], while swine influenza viruses are
reported to bind mainly α2-6 sialic acids but also α2-3
sialic acid receptors [9,10]. We previously found that
influenza viruses with HA from A/NWS/33 can bind to
α2-8 linked sialic acids [11], raising the possibility of
other forms of sialic acid receptor in human influenza
infection. A solid phase assay with multivalent sialylsac-
charides attached to a polyacrylamide backbone showed
that human isolates from the beginning of the H2N2 pan-
demic in 1957 and the 1968 H3N2 pandemic had four-
fold higher binding affinity to 6'sialyllactosamine than
avian viruses [12]. It was suggested that a change in recep-
tor binding specificity is a prerequisite for effective trans-
mission and replication to cause a new human pandemic.
However, some early H2 viruses preferentially bind 3'sia-
lyllactose [2,13] and the H5N1 isolates from humans
have been shown to have avian-like (α2-3) receptor spe-
cificity [14,15], although approximately equal binding to
α2-3 and α2-6 receptors was seen with two human H5N1
isolates [16].
Receptor binding specificities of recent H3N2 viruses have
not been studied in detail. Human influenza viruses were
able to agglutinate both human and chicken red blood
cells until the early to mid 1990s, when H3N2 and H1N1
influenza viruses lost the ability to agglutinate chicken red
blood cells but were still able to agglutinate human red
blood cells [17-20]. The responsible mutations in H3 HA
were suggested to be Glu190Asp [19] or the successive
changes of Gln226-to-Leu-to-Ile-to-Val [18]. Receptor
specificity of influenza viruses has been seen to correlate
with ability to agglutinate erythrocytes from different spe-
cies [21], although only a limited number of viruses and
species of red cells were investigated.
Due to the difficulties of obtaining and working with oli-
gosaccharides, many receptor specificity studies have
compared the binding of viruses to simple trisaccharides
such as α2-3- or α2-6- sialyllactosamine or sialyllactose
[22,23] in a competition assay to virus bound to a plate.
Alternative methods include virus overlays to gangliosides
separated by thin-layer chromatography [24,25] or
hemagglutination assays using red cells that were treated
with sialidase then re-sialylated using specific sialyltrans-
ferases [3,26,27]. The binding constant of a single sia-
lylated sugar chain to HA is typically in the mM range, so
multivalent binding is necessary to obtain a binding sig-
nal in a solid phase format [11,28,29]. Gambaryan et al.
studied the binding of duck viruses to multivalent sialyl-
oligosaccharides-PAA by competing the binding with
bovine fetuin labeled with horseradish peroxidase and
showed that binding affinity is higher with β1-3 rather
than β1-4 between the 2nd and 3rd sugar. Human viruses
showed higher binding affinity to sialyloligosaccharides
having a sulfo- group at position 6 of β1-4 linked GlcNAc
[30]. The development of printed covalent glycan arrays
by the Consortium for Functional Glycomics allows for
the first time a clear differentiation of what sugar struc-
tures bind to a given lectin [31-33]. The array has been
used to characterize the receptors for expressed HA of
1918 influenza viruses and H5N1 isolates, using multiple
antibody cross-linking to achieve the necessary level of
multivalency [15,34].
In the present study we used fluorescently labeled whole
virions to identify potential receptors for recent human
H3N2 viruses using glycan arrays. The results reveal that
all the recent H3N2 viruses bind to the same selection of
α2-6-sialylated oligosaccharides, and the chicken red cell
agglutination activity of recent viruses is not due to acqui-
sition of binding to α2-3 sialylsaccharides. Also we dem-
onstrate that the presence of α2-6 sialic acid on a cell
surface has little to do with its ability to be productively
infected by human influenza viruses.
Results
Chicken red blood cell agglutination
Most of the recent H3N2 isolates from Oklahoma aggluti-
nate chicken red blood cells, in marked contrast to viruses
isolated from about 1996 to 2003. One out of two 2003
isolates, four out of five from 2005, and four out of four
2006 isolates agglutinated chicken cells (Fig. 1). The
human to chicken cell hemagglutination ratios were close
to 1:1 for OK/Tf/03, OK/371/05, OK/372/05 and OK/
1992/05, and about 50:1 for OK/370/05. Memphis/98
(HG), OK/323/03, and OK/369/05 did not show any
agglutination with chicken red cells at the highest concen-
tration available (human:chicken >3000).
Binding of fluorescently labeled viruses to glycans
To investigate if there is a change in receptor specificity
between chicken red cell agglutinating and non-aggluti-
nating viruses, we used the Glycan Array of Core H of the
Consortium for Functional Glycomics. The printed array
v2 contained 264 natural and synthetic glycans [35]. Of
the 264 glycans, 76 possess sialic acid; 54 with α2-3 link-
ages, 22 with α2-6 linkages, and 7 with α2,8 linkages [31].
Binding was done at 4°C where the viral neuraminidase is
inactive. Experiments at higher temperature designed toVirology Journal 2007, 4:42 http://www.virologyj.com/content/4/1/42
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demonstrate cleavage of receptors by NA were not success-
ful, so there was no need to include an NA inhibitor in the
binding experiment. The array results are shown in Fig 2,
and Tables 1 and 2 list the glycans bound as percent of
total binding. "Total binding" is the sum of fluorescent
signals of all glycans that show ≥ 5% of the highest bind-
ing species.
All the recent H3N2 viruses, even the egg-adapted vaccine
reassortant Wyoming/03 X-147, show essentially identical
binding patterns. They bind to only a subset of the oli-
gosaccharides that have α2-6 sialic acid. The overall bind-
ing motif for the 2003–2005 viruses is shown in Fig 3A.
These viruses bind Neu5Acα2-6Galβ1-4GlcNAc motifs.
They do not bind if N-acetylneuraminic acid is hydroxy-
lated to the glycolyl form (Neu5Gc) or to 9-OAc sialic
acid; or if there is an additional α 2,8 linked sialic acid.
The GlcNAc at the third position is necessary for binding
and Glc is not tolerated at this position.
The 1982 vaccine virus A/Philippines/82 X-79 has broader
binding specificity as shown in Table 2 and Fig 3B. It
binds to Neu5Gcα2-6 as shown by Anders 1986 [36].
Unlike the later viruses, it binds a branched NeuAcα2-6
structure and also biantennary structures branched
through mannose. There is significant binding to
Neu5Acα2-3GalNAcβ1-4GlcNAcβ-Sp0 but not to other
α2-3 sialylated structures.
Mutation and red cell binding assay
The Glycoarray showed no specificity differences between
viruses that bind chicken red cells and those that do not,
suggesting the difference either involves structures that are
not on the array, or it is in affinity/avidity. Sequence com-
parisons of HA of H3N2 viruses showed only one correla-
tion between sequence and ability to agglutinate chicken
red cells; the non-agglutinating or very low agglutinating
2005 viruses have Ser or Thr at position 138 of HA1
instead of Ala. To investigate if this substitution affects
binding to chicken red cells we cloned and expressed the
HA genes of OK/323/03, OK/372/05, OK/369/05 wild
type and OK/369-S138A mutant in the baculovirus sys-
tem. Hemadsorption to HA-expressing Sf9 cells was seen
with human red cells for all constructs. Surprisingly, all
the HAs on Sf9 cells bound chicken red cells, even the OK/
369/05 wt and OK/323/03 HAs that did not agglutinate
chicken cells in the hemagglutination assay (Fig 4). We
also tested the released baculoviruses for agglutination
ability. All the recombinant baculoviruses showed good
HA titers with human red cells, but in contrast to the
hemadsorption result on Sf9 cells, none of the released
recombinant baculoviruses expressing the HAs of OK/
323/03, OK/372/05, OK/369/05 wild-type and OK/369-
S138A mutant were able to agglutinate chicken cells
(Table 3). The hemadsorption of chicken red cells to OK/
369/05 HA suggests that HA expressed in insect cells binds
with higher avidity than the HAs on recombinant baculo-
virus or influenza virus particles.
Red cell binding of influenza infected MDCK cells
The difference in chicken red cell binding to HA on Sf9
cells compared to influenza virus might be a function of
the lower complexity of N-linked glycans synthesized in
insect cells or due to differing density of HA molecules
between virus and cell surface. To distinguish between
these possibilities, we studied hemadsorption to influ-
enza infected MDCK cells. We found that MDCK cells
infected with OK/369/05 wild-type and OK/372/05 bind
to chicken red cells, while OK/323/03 infected MDCK
cells showed no significant binding to chicken cells (Fig.
4).
The results are summarized in Table 3. The efficiency of
binding chicken cells is in the order: HA on Sf9 cells > HA
on MDCK cells > influenza virus > HA on baculovirus
Binding, internalization, and replication of Memphis/31/98 
(HG)
We wanted to determine if the ability to agglutinate
chicken red cells correlates with ability to infect different
cell lines. For these experiments a relatively high concen-
Hemagglutination titers of recent viruses with chicken and  human red blood cells Figure 1
Hemagglutination titers of recent viruses with 
chicken and human red blood cells. The viruses were 
grown in MDCK cells and concentrated by centrifugation to 
obtain a ratio of HA titer with chicken red cells compared to 
human red cells. For Mem/31/98, OK/323/03 and OK/369/05 
there was still no agglutination of chicken red blood cells. 
The 2006 viruses were not concentrated. The data are aver-
age ± standard deviation of 3 experiments.
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Binding of viruses to the Glycan Array Figure 2
Binding of viruses to the Glycan Array. Glycan printed array V2 binding analyses of A/Oklahoma/323/03 (A), egg adapted 
vaccine reassortant A/Wyoming/03/03 X-147 (B), A/Oklahoma/369/05 (C), A/Oklahoma/1992/05 (D), and an older vaccine 
strain A/Phillipines/2/82 X-79 (E). The microarray slides used for these experiments had 246 glycans, shown along the X axis. 
The shaded regions show the α2-6-sialylsaccharides. The fluorescence is the average of 4 replicate spots ± standard error after 
the highest and lowest readings of six were excluded. OK/369/05 and OK/323/03, that do not bind chicken red cells, bind to 
the same α2-6-sialylsaccharides as do agglutinating and vaccine strain egg grown viruses.










     	  
        	  
        	 





	


 Neu5Acα2-6xxx

	



	

	

	

	

     	  
        	  
        	 





	


	

	

	

	

	
     	  
        	  
        	 











	

     	  
        	  
        	 





	

	

	

	

	

	
     	  
        	  
        	 





14 α-Neu5Ac Sp8
15 α-Neu5Ac Sp82
54 Neu5Acα2-6Galβ1-4GlcNAcβ1-2Manα1-3 
(Neu5Acα2-6Galβ1-4GlcNAcβ1-2Manα1-6) 
Manβ1-4GlcNAcβ1-4GlcNAcβ-Sp8 
 
53 same as 54 except Gly replaces Sp8
124 Galβ1-3(Neu5Acα2-6)GlcNAcβ1-4Galβ1-4Glcβ-Sp10
 Neu5Acα2-3GalNAcβ1-4GlcNAcβ-Sp0 215
Neu5Gcα2-6Galβ1-4GlcNAcβ Sp0 263
1-3 AGP
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B
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Table 1: Glycans bound by 2003–2005 H3N2 viruses
Glycan # Glycan Percent of total binding
369/05 1992/05 370/05 323/03 Wyoming Philippines
247 Neu5Acα2-6Galβ1-4GlcNAcβ1-3Galβ1-4(Fucα1-3)GlcNAcβ1-
3Galβ1-4(Fucα1-3)GlcNAcβ-Sp0
16 27 20 19 31 6
246 Neu5Acα2-6Galβ1-4GlcNAcβ-Sp8 16 13 14 16 6 6
248 Neu5Acα2-6Galβ1-4GlcNAcβ1-3Galβ1-4 GlcNAcβ-Sp0 15 26 17 16 22 6
243 Neu5Acα2-6GalNAcβ1-4GlcNAcβ-Sp0 15 18 14 18 17 6
244 Neu5Acα2-6Galβ1-4 [6OSO3]GlcNAcβ-Sp8 12 10 13 13 6 6
245 Neu5Acα2-6Galβ1-4GlcNAcβ-Sp0 11 3 14 16 4 6
54 Neu5Acα2-6Galβ1-4GlcNAcβ1-2Manα1-3 (Neu5Acα2-6Galβ1-
4GlcNAcβ1-2Manα1-6)Manβ1-4GlcNAcβ1-4GlcNAc-Sp8
404 1 0 6
53 Neu5Acα2-6Galβ1-4GlcNAcβ1-2Manα1-3 (Neu5Acα2-6Galβ1-
4GlcNAcβ1-2Manα1-6) Manβ1-4GlcNAcβ1-4GlcNAc-Gly
304 1 0 6
242 Neu5Acα2-6GalNAcα-Sp8 1 0 0 0 3 6
203 NeuAcα2-8NeuAcα2-8NeuAcα2-8NeuAcα2-3(GalNAcβ1-4)Galβ1-
4Glcβ-Sp0
3
231 Neu5Acα2-3Galβ1-4(Fucα1-3)GlcNAcβ-Sp8 4
253 Neu5Acα2-8Neu5Acα2-3Galβ1-4Glcβ-Sp0 4
tration of virus is required, so the viruses were grown in
chicken eggs. We used Memphis/31/98 (HG), a high
growth reassortant with A/NWS/33 internal genes that
grows to high titer in chicken eggs yet does not agglutinate
chicken red cells, and we compared it to the NWSHA-
Mem/31/98NA (H1N2) reassortant. We do not have Gly-
coarray results for Memphis/31/98 (HG) but used bioti-
nylated PAA-oligosaccharides to investigate binding
specificity as described for NWS-Memphis/31/98 [11].
The results (Fig. 5) show that Memphis/31/98 (HG) binds
to 6'-SLN with high affinity (Kd(app) = 0.14 arbitrary units)
and to 3'-SL with low affinity (Kd(app) = 0.68). Binding to
6'-SL, 3'-SLN, and 8'-polySA is very low. Results for NWS-
Mem/98 were reported previously and showed the same
specificity except for low affinity binding to 8'-polySA
[11].
Binding of virus, internalization, and synthesis of viral
protein were studied using a polyclonal antibody that
binds nucleoprotein (NP) [37] and Alexa488 labeled sec-
ondary antibody, with hemadsorption to detect newly
synthesized HA that has been transported to the cell sur-
face. Lectin binding (not shown) indicated that MDCK,
HeLa, and A549 cells have both α2-3- and α2-6- sialic
acids at the surface but CHO cells stained only with Maac-
kia lectin that binds α2-3-sialic acids in accord with the
observation that CHO cells have no 6'sialyltransferase
[38].
The results (Fig. 6) show that both Memphis/31/98 (HG)
and NWS-Mem/98 viruses can infect all four cell lines,
although with different efficiencies. NP was amplified in
all cell lines and HA was expressed on the cell surface.
Table 2: Additional glycans that bound only to Philippines/2/82 X-791
Glycan # Glycan Philippines
263 Neu5Gcα2-6Galβ1-4GlcNAcβ-Sp0 7
14 Neu5Ac-Sp8 7
124 Galβ1-3(Neu5Acα2-6)GlcNAcβ1-4Galβ1-4Glcβ-Sp10 6
15 Neu5Acα1-2-Sp82 5
250 Neu5Acα2-6Galβ1-4Glcβ-Sp8 4
251 Neu5Acα2-6Galβ-Sp8 4
215 Neu5Acα2-3GalNAcβ 1-4GlcNAcβ-Sp0 4
264 Neu5Gcα-Sp8 4
249 Neu5Acα2-6Galβ1-4Glcβ-Sp0 2
221 Neu5Acα2-3Galβ1-3(Neu5Acα2-6)GalNAcα-Sp8 2
235 Neu5Acα2-3Galβ1-4GlcNAcβ1-3Galβ1-4GlcNAcβ1-3Galβ1-4GlcNAcβ-Sp0 1
219 Neu5Acα2-3Galβ1-3(Neu5Acα2-3Galβ1-4)GlcNAcβ-Sp8 1
229 Neu5Acα2-3Galβ1-4(Fucα1-3)GlcNAcβ1-3Galβ1-4(Fucα1-3)GlcNAcβ1-3Galβ1-4(Fucα1-3)GlcNAcβ-Sp0 1
1 Results are given as percent of total bindingVirology Journal 2007, 4:42 http://www.virologyj.com/content/4/1/42
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Only MDCK cells release measurable virus, as assayed by
infectivity.
Discussion
Receptor specificity and amino acid changes in the HA1 of 
recent H3 viruses
A switch in receptor specificity from α2-3- linked sialic
acids to α2-6-linked sialic acids has been suggested as nec-
essary for influenza A viruses to adapt from avian to
human hosts [39-41]. Mutation of 2 amino acid residues
of H3 HA1, Q226L and G228S, was shown to change α2-
3 to α2-6 specificity of H3 HA. In H1 HA, "avian" residues
Gln226 and Gly228 are present in human viruses, but one
amino acid change, E190D of HA1 subunit has been
shown to be important in binding the α2-6 human recep-
tor [4,12,19,21,26]. However, H5N1 viruses isolated from
humans display the α2-3 receptor-binding properties that
are typical of avian viruses [14,15]. This indicates that an
avian virus does not need to change receptor specificity to
replicate efficiently in humans. The mutations that can
convert avian H1 and H3 serotypes to human receptor
specificity did not show this switch when they were
inserted into H5 HA, although binding to a branched α2-
6-biantennary glycan was acquired [15].
Human or avian host specificity was reported to correlate
with species of red blood cells bound [21] but in fact
chicken red cells were routinely used to measure human
virus until the 1990s, when human isolates of H3N2 and
Table 3: Comparison of HA titer of influenza and baculoviruses with hemadsorption to insect and mammalian cells expressing HA.
Hemagglutination titer Hemadsorption (A540)1
Influenza virus Recombinant baculovirus2 MDCK cells Sf9-cells
Human Chicken Human Chicken Human Chicken Human Chicken
OK/323/03 64 0 512 0 0.73 ± 0.07 0.03 ± 0.005 0.71 ± 0.02 0.26 ± 0.06
OK/369/05 wt 64 0 128 0 0.76 ± 0.02 0.20 ± 0.005 0.80 ± 0.09 0.26 ± 0.03
OK/369/05 S138A N/A3 N/A 64 0 N/A N/A 0.82 ± 0.07 0.31 ± 0.08
OK/372/05 64 32 64 0 0.74 ± 0.004 0.40 ± 0.01 1.05 ± 0.09 0.35 ± 0.06
1 Mean of 4 experiments ± standard deviation
2 Baculovirus was concentrated 10-fold before HA titration
3 N/A = not applicable
Binding motifs of H3N2 viruses Figure 3
Binding motifs of H3N2 viruses. The minimal motifs 
bound by 2003–2005 H3N2 viruses (A) and A/Philippines/2/
82/X-79 (B). Recent viruses require a minimum of 3 sugars to 
bind while Philippines binds a disaccharide. It can accommo-
date an N-glycolyl in place of N-acetyl on the terminal sialic 
acid.
Hemadsorption of chicken and human red blood cells to cell  surface-expressed HA Figure 4
Hemadsorption of chicken and human red blood cells 
to cell surface-expressed HA. Red cells were bound to 
recombinant HA expressed on the surface of Sf-9 cells and 
to influenza HA expressed on MDCK cells. Bound red cells 
were lysed with water and released hemoglobin was meas-
ured at 540 nm. The results shown are an average of 4 
experiments ± standard deviation.
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H1N1 were found not to agglutinate chicken red cells
[18,19,42]. For H3N2 viruses, mutagenesis and hemad-
sorption studies of A/Aichi/51/92 and A/Chiang Mai/
156/88 indicated that a change of E190D of Aichi/92 was
responsible for non-agglutination activity with chicken
rbcs [19]. Phenotypic variants of A/Paris/97 (H3N2) that
reacquired chicken agglutination ability had V226I, and/
or S193R and L194I changes [18].
We looked for sequence changes that might be involved in
the ability of 2003–2006 H3N2 viruses to agglutinate
chicken red cells. Amino acids previously reported to be
involved in the loss of chicken red cell agglutination, at
positions 190, 193, 194, and/or 226, show no correlation
with the red cell binding property. A new N glycosylation
site at 144 is present in HA1 of viruses from 2002–2006,
but the extra glycosylation is present in all isolates,
whether or not they agglutinate chicken red cells. We
identified a change of Ala138 to Ser or Thr that was
unique to the two 2005 isolates that did not bind chicken
red cells, but the mutation S138A in A/OK/369/05 had no
effect on the binding properties of the HA.
Glycan binding analysis
We used fluorescently labeled influenza viruses to probe
the Glycan Array to obtain comparative data beyond the
α2-3- and α2-6- linkage for these viruses. We expected to
find a difference in the glycan binding pattern between
chicken red cell agglutinating and non-agglutinating
groups, but all the recent viruses in our study, OK/323/03,
OK/369/05, OK/370/05, and OK/1992/05, bound to the
same group of α2-6-linked oligosaccharides. There was no
binding to α2-3-glycans (Fig. 2, Table 1). All the recent
human H3N2 viruses, including egg grown A/Wyoming/
03/03 X-147, bind to a minimum binding motif:
Neu5Acα2-6Galβ1-4GlcNAc, as in polylactosamine struc-
tures found on N- and O- linked carbohydrates or
Neu5Acα2-6GalNAcβ1-4GlcNAc- (Fig 3A). In general the
recent viruses showed higher binding to longer and fuco-
sylated oligosaccharides. The vaccine strain A/Wyoming/
03/03 X-147 bound to a somewhat restricted set of α2-6
sialic acids, with low binding to some α2-3 sialylated gly-
cans (Fig 2). The egg-adapted A/Philippines/2/82 X-79
bound to the same set of α2-6 sialylated oligosaccharides
as the recent viruses and, in addition, one α2-3 sialylated
oligosaccharide with low binding to several other α2-3
structures, a branched α2-6, two biantennary sialylsaccha-
rides branched through mannose at position 4 and two
oligosaccharides containing Neu5Gcα2-6Galβ1-
4GlcNAc. (Table 2). The binding to Neu5Gc was previ-
ously noted to be associated with a mutation of Thr to Tyr
at 155 of HA1 [36]. The Tyr155 changed to His in 1989
and then back to Thr in 2002. A/Moscow/99 [34] and the
recent viruses studied here no longer bind Neu5Gc.
Hemagglutination is not the same as hemadsorption
Hemagglutination and hemadsorption generally give the
same results [18,43], but we found significant differences
in these assays. Table 3 shows that the same HA can bind
chicken red cells in one condition (HA expressed on Sf9
cells and/or MDCK cells) and not others (HA on MDCK
cells or virus titrated for HA activity). The released baculo-
viruses that contain the same HA did not agglutinate
chicken red cells. It is likely that only a relatively low
amount of HA becomes packaged in released baculovi-
ruses, but good titers were obtained with human red cells.
Therefore the density of HA may be a critical factor in the
ability of a given HA to agglutinate chicken red cells, per-
haps determined by other genes since the HA sequences
did not show consistent differences.
The interaction between an HA trimer and a monovalent
sialylsaccharide is of low affinity (~1 mM) and a large
increase in avidity of influenza virus to host cells through
multivalent binding via a high density of HA molecules
on the virus surface has been assumed [44,45]. Our results
suggest that the HA density is higher on the cell surface
than on virus particles, perhaps due to the increased cur-
vature of the virion surface. Lectin staining of red blood
cells has suggested α2-6 receptors are more abundant on
human than chicken red cells and so allow binding even
when the HA is less densely packed [19].
Hemadsorption on insect cells is not the same as on MDCK 
cells
The lack of chicken red cell hemadsorption activity of OK/
323/03 HA expressed on MDCK cell surface, when com-
Binding of biotinylated α2-3- and α2-6- linked sialic acid  PAA-compounds to Memphis/31/98 (HG) Figure 5
Binding of biotinylated α2-3- and α2-6- linked sialic 
acid PAA-compounds to Memphis/31/98 (HG). Oli-
gosaccharide bound to virus immobilized in wells of a micro-
titer plate was detected by AP-streptavidin as described in 
the Methods. The data points are mean of triplicates ± stand-
ard deviation. The line is the fit of the data to the standard 
binding equation generated using Kaleidagraph software. A 
similar experiment that shows the binding specificity of 
NWS-Mem/98 has been published [11].Virology Journal 2007, 4:42 http://www.virologyj.com/content/4/1/42
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pared to HA on Sf-9 cells, could potentially be due to the
differences in the glycosylation machinery. The smaller
glycans on HA expressed in insect cells may allow better
access of sialylated receptor molecules to the binding site.
Loss of a glycan from HA has been shown to increase its
affinity for receptors [46-48]. However, neither the
smaller glycans in insect cells nor the action of the viral
NA can explain the results in Table 3, leading us to con-
clude that the change is in avidity rather than affinity and
that HA density accounts for the differences.
Receptor availability does not necessarily lead to 
productive infection
MDCK, HeLa, and A549 cells have both α2-3- and α2-6-
sialic acids at the surface. CHO cells have only α2-3-sialic
acids in accord with the observation there is no 6'sialyl-
transferase [38]. Mem/31/98 and NWS-Mem/98 bind to
α2-6-siayllactosamine, but show no or little binding,
respectively, to α2-3- sialyllactosamine. Both viruses show
some binding to 3'sialyllactose, but this oligosaccharide is
not present on cell surface. We expected these viruses to
show little or no entry into CHO cells, but Fig 6 shows
internalization and production of viral proteins of Mem/
31/98 and NWS-Mem/98 in all four cell lines, including
CHO cells. There is no release of progeny virus from HeLa,
CHO or A549 cells. Productive infection of A/WSN/33 in
HeLa cells has been found to be impeded at several stages
of replication, including budding and release [49] as we
see with Mem/98 and NWS-Mem/98 viruses.
The synthesis of viral proteins of Mem/31/98 in CHO cells
shows that α2-6-sialic acid receptors are not necessary for
virus infection and replication in the cell, in accord with
previous studies that influenza viruses can enter cells in
the absence of any surface sialic acid [50]. Cells that have
high levels of α2-6 sialic acid on the surface (A549, HeLa)
are more efficiently infected but are not permissive for
productive infection.
Conclusion
Our data show that the change to chicken red cell aggluti-
nation ability of recent human clinical H3N2 isolates is
not associated with a change in receptor specificity to α2-
3-sialic acid. We see no consistent changes in HA sequence
associated with the binding change and so the change in
avidity that led to seemingly retrograde binding to
chicken red cells must be subtle; there may be no differ-
ence in affinity but the density of HA on Sf9 cells may give
significantly increased avidity. This emphasizes the point
that receptor binding properties of H3N2 viruses are con-
stantly changing. Our results further show that the pres-
ence of high levels of α2-6 receptors on HeLa and A549
cells does not guarantee the production of progeny virus.
We conclude that the sialic acid linkage on a cell surface is
not the most important determinant of infection.
Methods
Viruses
The viruses used in this study are A/OK/323/03 and A/
OK/Tf/03 [51], A/OK/369/05, A/OK/370/05, A/OK/371/
05, A/OK/372/05, A/OK/1992/05, A/OK/51/05, A/OK/
309/05, A/OK/1050/05, A/OK/1472/05, A/Memphis/31/
98 (HG) [52], NWS-Mem/31/98 [11]. The recent human
viruses were provided to us by Dr. Joseph Waner, Depart-
ment of Pediatrics, University of Oklahoma Health Sci-
ences Center, Oklahoma City, OK. The viruses were
isolated in primary rhesus monkey kidney cells (two pas-
sages) and were grown in Madin-Darby canine kidney
(MDCK) cells [53]. For comparison we used vaccine
strains A/Philippines/2/82 X-79 and A/Wyoming/03/03
X-147 (CDC) grown in embryonated chicken eggs. The
viruses were purified by sucrose gradient centrifugation
[54] and the purity was checked by SDS gel electrophore-
sis and silver stain.
Hemagglutination assay
The MDCK grown viruses were serially diluted in 50 µl of
PBS and 50 µl of washed chicken (0.5%) or human
(0.8%) red blood cells added. The plates were kept at 4°C
and hemagglutination was read at 90 min with human
blood and 60 min with chicken blood [55].
Sequencing
The HA and NA genes of the Oklahoma isolates were
amplified by RT-PCR using primers specific for H3 HA
and N2 NA. The PCR amplified DNA was gel purified and
sequenced at the Oklahoma Medical Research Founda-
tion sequencing facility using primers spaced approxi-
mately 500 nucleotides apart. The HA and NA gene
sequences of all the viruses have been submitted to the
Los Alamos Influenza Sequence Database [56].
Alexa Fluor-488 labeling of viruses
The purified virus was pelleted out of sucrose and resus-
pended in CMS (0.15 M NaCl, 0.25 mM CaCl2, 0.8 mM
MgCl2) to an HA titer of about 1.0 × 105 HAU/ml. To 100
µl (~1.0 × 104 HA units) virus we added 10 µl of 1.0 M
sodium bicarbonate pH 9.0. Alexa Fluor-488 succinimidyl
ester (Molecular Probes) was added in a ratio of 0.005 µg
Alexa per HAU, determined by HA titration to give maxi-
mal labeling without loss of binding activity. After stirring
for 1 hr at room temperature in the dark, the sample was
dialyzed (Slide-A-Lyzer Mini Dialysis Units 7000 MWCO,
Pierce) in CaMgS (0.25 mM CaCl2, 0.8 mM MgCl2 in
borate buffered saline, pH 7.2) at 4°C overnight. An aliq-
uot of the dialyzed virus was run on a 9% SDS-PAGE gel
to confirm fluorescence of HA1 with no labeling of inter-
nal proteins. The HA activity of labeled virus was checked
again to make sure binding sites were not inactivated by
the reagent.Virology Journal 2007, 4:42 http://www.virologyj.com/content/4/1/42
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Glycan binding of labeled virus
The protocol followed for binding studies is "cfgPTC_197:
Printed Glycoarray Screening" [35]. The slide contained a
total of 264 glycans: sialylsaccharides, other carbohy-
drates, and glycoproteins. 50 µl of Alexa-labeled virus was
applied to the printed surface of a slide and incubated at
4°C for 1 h. The slide was washed and dried under a
stream of nitrogen. The binding image was read in a Per-
kin-Elmer Microarray XL4000 scanner and analyzed using
Imagene (V.6) image analysis software.
Hemagglutinin cDNA cloning in baculovirus and protein 
expression
We used the "Bac-to-Bac" Baculovirus Expression System
(Invitrogen Life Technologies) to clone the HA gene. The
full length HA genes of OK/369/05, OK/323/03, and OK/
372/05 were amplified using HA specific forward and
reverse primers. The forward primer, 5'-ATAGGCCTGCG-
GCCGCATGAAGACTATCATTGCTTTG-3' has Stu1 and
Not1 restriction enzyme linker at the 5' end and the
reverse primer, 5'-GAACTGCAGCAATGGTGATGGTGAT-
GATGAATGCAAATGTTGCACC-3' has a 6-His tag before
the stop codon and a Pst1 linker at the 3' end. The PCR
amplified HA gene digested with Stu1 and Pst1 then puri-
fied by QIAquick PCR Purification Kit (Invitrogen),
cloned into the pFastBac vector, and propagated in E. coli
(One Shot TOP10; Invitrogen). The Stratagene's Quik-
Change XL Site-Directed Mutagenesis Kit was used to
make OK/369- S138A in the pFastBac plasmid. The
recombinant pFastBac plasmids were transformed into
DH10Bac™ E. coli cells that contain a baculovirus shuttle
vector and a helper plasmid, according to the manufac-
turer's instructions. The recombinant bacmid DNA was
purified from DH10Bac™ cells and used to transfect Sf-9
cells. Expression and functional activity of HA was assayed
by red cell binding to BacHA-expressing Sf-9 cells and by
hemagglutination titration of baculoviruses.
Hemadsorption and red cell binding
Sf-9 cells at 80% confluency (in T-25 tissue culture flask)
were infected with recombinant HA-baculoviruses. After 5
days of infection they were assayed for red cell binding to
surface-expressed HA. The cells were washed 3 times with
ice cold CaMgS, fixed lightly with 3% paraformaldehyde
for 5 min at 4°C, then washed 3 times with cold PBS. For
red cell binding, 4.0 ml of 1% red cells in PBS was added
to each flask and incubated for 2 hr at 4°C. The cells were
washed several times with PBS until all unbound red cells
were removed. To quantitate the amount of red cells
bound to each flask, 4.0 ml water was added to the
washed cells. After 2 hrs, the cells and debris were spun
out at 1,200 g and the clear supernatant was read at 540
nm. Red cell binding to influenza infected MDCK cells in
6 well plates was measured after 18 hrs of infection. To
normalize the results to the number of cells, we deter-
mined the total soluble protein in Bac-HA infected Sf-9
cells and influenza infected MDCK cells lysed with water.
The protein was assayed in cell lysates by Bradford BioRad
Protein Assay (BioRad, # 500-0006) and was 0.20 ± 0.004
mg/cm2 for Sf-9 cells and 0.08 ± 0.002 mg/cm2for MDCK
cells.
Virus internalization and replication
Cells were grown on cover slips in 35 mm plates. The cells
were washed three times with CaMgPBS and infected with
300 µl freshly grown virus from MDCK cells. The cells
Binding, internalization and synthesis of viral proteins in different cell lines Figure 6
Binding, internalization and synthesis of viral proteins in different cell lines. Surface binding of virus (4°C, 1hr), inter-
nalization (37°C,1hr), replication to amplify NP (37°C, 6 hr), and cell surface expression of HA seen by hemadsorption at 18 hr 
(rbc binding). Immuno staining and red cell binding was done as described in Methods.Virology Journal 2007, 4:42 http://www.virologyj.com/content/4/1/42
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were incubated at 4° for 1 hr to allow the virus to bind to
the cell surface and then transferred to 37°C for 1 hr, 6 hr,
and 18 hr. After 1 hr the virus is internalized and NP can
be detected as it concentrates in the nucleus. By 6 hr post-
infection new NP has been synthesized and higher levels
are seen in the nucleus. By 18 hr there is a sufficient sur-
face expression of HA for red cells to bind. To detect NP
the cells were washed twice with cold PBS and fixed with
1 ml freshly prepared 3% paraformaldehyde in PBS, on
ice for 5 min. After washing three times with cold PBS,
cells were permeabilized with 2% triton X-100 in PBS for
10 min at room temperature, washed 3 times with cold
PBS, once with 50 mM ammonium chloride in PBS to
destroy any remaining paraformaldehyde, and blocked
with 10% supplemented calf serum in PBS for 15 min at
room temperature. Fifty µl of rabbit anti-core (mostly
anti-NP) antiserum diluted 1:1000 in 0.1% BSA/PBS was
added for 30 min at RT. After washing with 0.1% BSA in
PBS, cells were incubated with 50 µl Alexa Fluor-488
labeled goat anti-rabbit antiserum (1:200 dilution) for 30
min at room temperature. After washing five times with
0.1% BSA/PBS and once with water, the cover slip was
drained well and mounted with a small drop of Vectash-
ield (Vector Laboratories Burlingame, CA). The slides
were examined and recorded on a Fluorescent Diaphot-
300 (Nikon Corporation) microscope with a Nikon
Dxm1200 digital camera.
Binding of Memphis/31/98 (HG) and NWS-Mem/31/98 to 
biotinylated PAA-oligosaccharides
Binding was measured as previously described [11]. The
ELISA plate was coated with 32 HAU of purified virus in
50 µl 0.15 M sodium carbonate, 0.3 M sodium bicarbo-
nate, pH 9, and incubated at 4°C overnight. The plate was
washed with PBS, blocked with 1% BSA in PBS for 1 hr,
and washed with PBS. Fifty µl of various dilutions of bioti-
nylated PAA oligosaccharide was added to give the desired
final concentration. After 1 hr incubation on ice the plate
was washed and the bound oligosaccharide was quanti-
tated by alkaline phosphatase-conjugated streptavidin.
The biotinylated oligosaccharides used were:
Neu5Acα2-3Galβ 1,4Glc (3'SL, 3' sialyllactose);
Neu5Acα2-3Galβ 1,4GlcNAc (3'SLN, 3' sialyllactos-
amine); Neu5Acα2-6Galβ 1,4Glc (6'SL, 6' sialyllactose);
Neu5Acα2-6Galβ1,4GlcNAc (6'SLN, 6' sialyllactos-
amine); Neu5Acα 2,8Neu5Acα 2,8Neu5Acα (8'polySA,
trisialic acid).
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